AS

Arpana Sachin Gavane

Active Director Director DIN 08359040
DIN 08359040 First appointment Feb 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value •••• Premium profile

About Arpana Sachin Gavane

Data last updated:

Arpana Sachin Gavane is a Director at Megacure Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Megacure Pharmaceuticals Private Limited reported revenue of ₹3 Lakh (FY 2017).

DIN 08359040
Primary Designation Director
Industry Trading
First Appointment 11 Feb 2019
Oldest Company Age 11 yrs
Largest company Megacure Pharmaceuticals Private Limited · ₹3 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Feb 20192015₹3 Lakh (FY 2017)Active

Board colleagues of Arpana Sachin Gavane

Directorship timeline

Open interactive timeline →
Megacure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arpana Sachin Gavane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpana Sachin Gavane

Arpana Sachin Gavane currently holds 1 directorship: Megacure Pharmaceuticals Private Limited (Director, since 11 Feb 2019, revenue ₹3 Lakh (FY 2017)).

Arpana Sachin Gavane was first appointed on 11 Feb 2019 as Director at Megacure Pharmaceuticals Private Limited.

The current boards of Arpana Sachin Gavane's companies include Sachin Nilkanth Gavane (Megacure Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available